Please check your internet connection and try again.
# Sompraz hp (Pantoprazole)
## Overview
Sompraz hp is a brand name for pantoprazole, a proton pump inhibitor (PPI). It works by reducing the amount of acid produced in the stomach.
## Primary Indications
* Gastroesophageal reflux disease (GERD) - symptomatic treatment and healing of erosive esophagitis.
* Zollinger-Ellison syndrome.
* Part of combination therapy for the eradication of *Helicobacter pylori* infection.
## Adult Dosing
* **GERD/Erosive Esophagitis:** 40 mg once daily. Doses may be increased to 40 mg twice daily for severe cases. Maintenance therapy is typically 40 mg once daily.
* **Zollinger-Ellison Syndrome:** Starting dose is typically 40 mg twice daily. Doses should be individualized and adjusted based on gastric acid output. Doses can range up to 80 mg twice daily.
* ***H. pylori* Eradication:** As part of a triple or quadruple therapy regimen, commonly 40 mg twice daily for 7-14 days.
## Pediatric Dosing
Dosing in pediatric patients varies significantly by age and indication. Consult specific pediatric guidelines. Generally:
* **GERD/Erosive Esophagitis (ages 5-16 years):** 20-40 mg once daily.
* Dosing for younger children or other indications is less established and requires careful consideration of risk vs. benefit.
## Dose Adjustments
No dose adjustment is typically required for renal impairment.
For hepatic impairment, the maximum recommended daily dose is 20 mg once daily.
## Contraindications
* Known hypersensitivity to pantoprazole, other PPIs, or any component of the formulation.
## Adverse Effects
Common adverse effects include:
* Headache
* Diarrhea
* Nausea
* Abdominal pain
* Dizziness
* Flatulence
Long-term PPI use may be associated with:
* Increased risk of *Clostridium difficile*-associated diarrhea.
* Bone fractures (hip, wrist, spine).
* Hypomagnesemia.
* Vitamin B12 deficiency.
## Key Drug Interactions
* **Drugs requiring gastric acid for absorption:** Ketoconazole, itraconazole, iron salts, some HIV protease inhibitors (e.g., atazanavir, nelfinavir). Administer at least 2 hours before or 2 hours after pantoprazole.
* **Warfarin:** May increase INR and prothrombin time. Monitor INR closely.
* **Methotrexate:** High-dose methotrexate may be elevated by PPIs. Consider temporarily discontinuing PPI.
* **CYP2C19 substrates:** Pantoprazole is a moderate inhibitor of CYP2C19; caution with other drugs metabolized by this enzyme.
## Monitoring
* Monitor for relief of GERD symptoms.
* Monitor for signs and symptoms of *C. difficile* infection.
* Consider magnesium levels with prolonged therapy, especially in patients taking diuretics or digoxin.
* Monitor bone mineral density with long-term use, especially in at-risk individuals.
## Clinical Pearls
* Administer pantoprazole 30 minutes before a meal.
* Pantoprazole delayed-release tablets should be swallowed whole and not crushed or chewed.
* While typically well-tolerated, consider the risks associated with long-term PPI use and use the lowest effective dose for the shortest duration necessary.
* For *H. pylori* eradication, ensure patient adherence to the full antibiotic regimen.
***
**Disclaimer:** This information is intended for clinical professionals and is not a substitute for comprehensive prescribing information. Always consult the most current product monograph and relevant clinical guidelines for definitive dosing and safety information.
